ConductScience.org, home

Trial · NCT03156621

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Double-Blind Treatment Period (DBTP)STARTEDPlacebo in DBTP24
Double-Blind Treatment Period (DBTP)STARTEDAlirocumab 150 mg SC Q2W45
Double-Blind Treatment Period (DBTP)COMPLETEDPlacebo in DBTP24
Double-Blind Treatment Period (DBTP)COMPLETEDAlirocumab 150 mg SC Q2W45
Double-Blind Treatment Period (DBTP)NOT COMPLETEDPlacebo in DBTP0
Double-Blind Treatment Period (DBTP)NOT COMPLETEDAlirocumab 150 mg SC Q2W0
Open-Label Treatment Period (OLTP)STARTEDPlacebo in DBTP24
Open-Label Treatment Period (OLTP)STARTEDAlirocumab 150 mg SC Q2W45
Open-Label Treatment Period (OLTP)COMPLETEDPlacebo in DBTP24
Open-Label Treatment Period (OLTP)COMPLETEDAlirocumab 150 mg SC Q2W42
Open-Label Treatment Period (OLTP)NOT COMPLETEDPlacebo in DBTP0
Open-Label Treatment Period (OLTP)NOT COMPLETEDAlirocumab 150 mg SC Q2W3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03156621/flow